Drug Profile
AJW 200
Alternative Names: AJvW 2Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ajinomoto
- Class Monoclonal antibodies
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Thrombosis in United Kingdom (IV, Infusion)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in Japan (IV, Infusion)
- 20 Aug 2003 Phase-I clinical trials in Thrombosis in United Kingdom (unspecified route)